Risk Factors Linked to the Occurrence of Neurological Signs Following Poisoning by Cosmetic Products in Morocco (1981-2011)

  • Rajaa Bellaje Laboratory of Genetics and Biometrics, Faculty of Sciences, Ibn Tofail University, Kenitra, Morocco Poison and Pharmacovigilance Center of Morocco, Rabat, Morocco
  • Houda Sefiani Laboratory of Genetics and Biometrics, Faculty of Sciences, Ibn Tofail University, Kenitra, Morocco Poison and Pharmacovigilance Center of Morocco, Rabat, Morocco
  • Doha Ben Ali Laboratory of Genetics and Biometrics, Faculty of Sciences, Ibn Tofail University, Kenitra, Morocco
  • Soufiane Adnani Biology and Health Laboratory, Faculty of Sciences, Ibn Tofail University, Kenitra, Morocco
  • Abdelmajid Soulaymani Laboratory of Genetics and Biometrics, Faculty of Sciences, Ibn Tofail University, Kenitra, Morocco
  • Rachida Soulaymani-Bencheikh Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco Poison and Pharmacovigilance Center of Morocco, Rabat, Morocco
Keywords: Retrospective study; Cosmetic; poisoning; lightening creams; neurological signs; Poison and pharmacovigilance center of Morocco

Abstract

Objectives: The objective of this study is to determine the risk factors associated with the onset of neurological disorders during poisoning by cosmetic products. Methods: This is a retrospective study of all cases of poisoning by industrial cosmetic products reported to the Poison and pharmacovigilance center of Morocco over a period of 30 years from January 1981 to the end of December 2011. Results: During the study period, 431 cases were reported with a sex ratio (F/M=1.66). Hair products and skin products are the most incriminated with 48% and 32.5% respectively. Clinical signs are described in 51% of cases with a clear predominance of gastrointestinal system disorders (39% of cases), followed by nervous system signs (17.8% of cases). Oral administration was the most common route with 84% of cases. Logistic regression analysis allows us to qualify poisoning by skin lightening creams as the only predictive factor strongly associated with the occurrence of neurological signs (p = 0.011). Conclusions: The establishment of very precise regulations with clarity concerning the law governing cosmetic products will certainly ensure better orientation of care in the event of a declaration of poisoning.

Downloads

Download data is not yet available.

References

1. Agence française de sécurité sanitaire des produits de santé (afssaps). (2011). Évaluation des risques liés à la dépigmentation volontaire.
2. Bonnard, N., Pillière, F., Protois, J.C., Schneider, O. (2006). FICHE TOXICOLOGIQUE de l’Hydroquinone. FT 159. Institut National de Recherche et de Sécurité (INRS).
3. Guyodo, G. (2003). Intoxications chez l’enfant. Données du Centre Anti Poison de Grenoble. Congrès de la Société Française de Toxicologie. Cassis.
4. Kwa, M., Welty, L. J., Xu, S. (2017). Adverse Events Reported to the US Food and Drug Administration for Cosmetics and Personal Care Products. JAMA Intern Med; 177(8):1202-1204.
5. Direction du Médicament Et de la Pharmacie (DMP) (2006). Circulaire N°: 04 DMP/21/CPV.https://pharmacie.ma/uploads/pdfs/circulaire_04DMP-21 CPV_du_09_01_2006.pdf.
6. Nolf, MM. (2001). Rapport annuel d’activité du Centre Antipoison et de Toxicovigilance de Lille.
7. Oualid, E. (2011). Les produits dépigmentants. (2011). Pharmaceutical sciences. HAL Id: dumas-00630594 http://dumas.ccsd.cnrs.fr/dumas-00630594.
8. Ruggiero, S., Moro, P. A., Davanzo, F., Capuano, A., Rossi, F., Sautebin, L. (2012). Evaluation of cosmetic product exposures reported to the Milan Poison Control Centre, Italy from 2005 to 2010. Clin Toxicol (Phila) ; 50(10):902-10. doi: 10.3109/15563650.2012.740484. Epub 2012 Nov 8.
9. Scozzafava, A., Kalın, P., Supuran, C. T., Gülçin, İ., Alwasel, S. H. (2015). impact of hydroquinone on acetylcholine esterase and certain human carbonic anhydrase isoenzymes (hCA I, II, IX, and XII). J Enzyme Inhib Med Chem, 14:1-6.
10. Searchlight Pharma Inc. Monographie de produit incluant les renseignements pour le patient sur le médicament. Prerfa hydroquinone. Gel d’hydroquinone gel, 4 % p/p, pour usage externe. Pour usage externe seulement agent anti-hyperpigmentation. 29 septembre 2022.
11. The Toxin and Toxin Target Database (T3DB). Quinone (T3D4578). http://www.t3db.ca/toxins/T3D4578.
Published
2026-02-20
How to Cite
Bellaje, R., Sefiani, H., Ben Ali, D., Adnani, S., Soulaymani, A., & Soulaymani-Bencheikh, R. (2026). Risk Factors Linked to the Occurrence of Neurological Signs Following Poisoning by Cosmetic Products in Morocco (1981-2011). European Scientific Journal, ESJ, 50, 432. Retrieved from https://eujournal.org/index.php/esj/article/view/20660
Section
ESI Preprints